Gossamer Bio (GOSS) Debt/EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| Debt/EBITDA | 0.67 | 0.14 | 0.52 | 2.29 | -0.40 | -0.41 | ||
| Changes by years, y/y, % | -52% | -79% | +266% | +342% | -117% | |||
Gossamer Bio. Debt/EBITDA
Gossamer Bio. Debt/EBITDA, changes, %
Gossamer Bio (GOSS) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| Debt/EBITDA | 2.29 | 1.54 | 0.08 | -0.16 | -0.41 | -0.41 | ||
| Changes by years, y/y, % | +342% | +578% | -97% | -107% | -118% | |||
| Changes by quarters, q/q, % | -3% | -33% | -95% | -298% | +162% | |||